Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 4/3/17 → 4/2/19 |
Funding
- Hoosier Cancer Research Network ( Award # ): $11,500.00
Randomized Phase II Trial of Docetaxel plus Nivolumab or Docetaxel alone in patients with advanced non-squamous NSCLC and previous clinical benefit on treatment with single agent Nivolumab HCRN LUN15-233
- Willis, Maurice (PI)
Project: Research project